isomorphic labs
-
The Architects Before the Gold: DeepMind and Isomorphic Labs
Demis Hassabis and John Jumper solved protein folding, leading to Isomorphic Labs’ $2.1 billion Series B. The company now targets clinical trials…
-
Biggest trends in AI drug discovery startups
Venture capital is concentrating in massive compute-heavy platforms like Isomorphic Labs, which closed a $2.1 billion Series B. While companies like Insilico…
-
AlphaFold 3 and Isomorphic Labs drug design capabilities
AlphaFold 3 utilizes a diffusion module to predict complex biomolecular interactions, including DNA and RNA. Isomorphic Labs leverages this technology through major…
-
Isomorphic Labs secures $3 billion in pharma alliances
Isomorphic Labs has signed strategic partnerships with Eli Lilly and Novartis valued at nearly $3 billion. The deals leverage AlphaFold 3 technology…